| Huang, John (TheWell Bioscience 202404 CEO + Founder) |
Chief Executive Officer (CEO) |
TheWell Bioscience Inc. |
United States (USA) |
| Huang, Keith (Schauenburg 201911– Regional Manager Asia Pacific at Markes before Agilent) |
Regional manager |
Schauenburg (Group) |
China |
| Huang, Rani (RayBiotech 201408 COO + Co-founder) |
Chief Operating Officer (COO) |
RayBiotech Inc. |
United States (USA) |
| Huang, Song (Epithelix 201207 CSO + Co-founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Epithelix Sàrl |
Switzerland |
| Huang, Vanessa (BVCF Management 202105 General Partner) |
General Partner (venture partner) |
BVCF Management Ltd. (CN) (BioVeda China Fund) |
China |
| Huang, Yanshan (Doer Biologics 202307 CEO + Founder) |
Chief Executive Officer (CEO) |
Doer Biologics (Group) |
China |
| Huang, Yingying (Thermo Fisher 200810 Strategic Marketing Specialist Metabolism and Metabolomics group) |
Sales Manager / Marketing Manager |
Thermo Fisher (Group) |
United States (USA) |
| Hubbard, John (Pfizer 201312 SVP + Global Head of Development Operations) |
President/Director/Head Business Group/Unit/Division |
Pfizer (Group) |
United States (USA) |
| Hubbell, Jeffrey A. (Anokion 201701 Chairman + CSO + Academic Founder + Prof at Univ Chicago + before at EPFL) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Anokion (Group) |
Switzerland |
| Huber, Andreas (Bayern (Govt) 201310 Senior Investment Manager at Bayern Kapital) |
Investment Manager |
Bavaria (govt region) |
Germany |
| Huber, Caroline (Tecan 201211 Senior Market Manager) |
Sales Manager / Marketing Manager |
Tecan (Group) |
Switzerland |
| Huber, Christian (Univ Salzburg 201310 Professor + Head of CD Lab for Biosimilar Characterization) |
Professor |
University of Salzburg |
Austria |
| Huber, Christoph (CI3 Cluster 201307 Board Member of CI3 e.V.) |
n. a. |
Ci3 Cluster (Cluster für Individualisierte ImmunIntervention e. V.) |
Germany |
| Huber, Fritz (LipoFIT GmbH 201204 Managing Director + Co-founder) |
Managing Director |
Numares (Group) |
Germany |
| Huber, Hans (Biomay 201505 COO) |
Chief Operating Officer (COO) |
Biomay AG |
Austria |
| Huber, Jutta (Eurofins 201405 Managing Director Eurofins Genomics GmbH before MWG Biotech) |
Managing Director |
Eurofins (Group) |
Germany |
| Huber, Lukas (Medical Univ Innsbruck 201211 Professor + Director of the Biocenter) |
Professor |
Medical University Innsbruck (MUI) |
Austria |
| Huber, Mario (PharmaMar 201612– Managing Director of PharmaMar Austria before Quintiles) |
Managing Director |
PharmaMar (AT) |
Austria |
| Huber, Martin (Quantapore 201406 CEO + Founder before Ion Torrent) |
Chief Executive Officer (CEO) |
Quantapore Inc. |
United States (USA) |
| Huber, Robert (Univ Duisburg-Essen 201004 Professor ZMB before Max Planck Institute for Biochemistry, Nobel Laureate) |
Professor |
University of Duisburg-Essen |
Germany |
| Huber, Roman (Bayern Kapital 200612 Managing Director) |
Managing Director |
Bavaria (govt region) |
Germany |
| Huber, Walter (Merck 200601) |
n. a. |
Merck (DE) (Group) |
Germany |
| Huber-Saffer, Peter (Chiesi 201410 Business Development Manager at Chiesi GmbH) |
Business Development Manager / Strategy Manager |
Chiesi (Group) |
Germany |
| Huc, Jean-Francois (BioAmber 201207 CEO) |
Chief Executive Officer (CEO) |
BioAmber (Group) |
United States (USA) |
| Huchler, Roland (InnoCyte GmbH 201211 Managing Director + Founder) |
Managing Director |
InnoCyte GmbH |
Germany |
| Hudson, Paul (Sanofi 201909– CEO before Novartis Head Pharma before AstraZeneca + Schering-Plough) |
Chief Executive Officer (CEO) |
Novartis (Group) |
Switzerland |
| Hue, Baudouin (Karista 202206 Partner) |
Partner (venture partner) |
Karista (FR) |
France |
| Huebscher, Karen (Solvias 201403– CEO before Novartis) |
Chief Executive Officer (CEO) |
Solvias (Group) |
Switzerland |
| Hueffer, Johan (Novo Group 202405 Senior Partner, Principal Investments at Novo Holdings) |
Partner (venture partner) |
Novo Group (Group) |
Denmark |
| Huels, Christoph (Protagen 200704 CEO) |
Chief Executive Officer (CEO) |
Freenome (Group) |
Germany |
| Huelso, Gerd (Bruker 201310 Managing Director at Bruker Daltonik GmbH) |
Managing Director |
Bruker (Group) |
Germany |
| Huenges, Martin (Maiwald Patentanwalts GmbH 200809 Munich) |
n. a. |
Maiwald Patentanwalts GmbH (Munich) |
Germany |
| Huff, Warren (Reata Pharmaceuticals 202307 CEO) |
Chief Executive Officer (CEO) |
Biogen (Group) |
United States (USA) |
| Hufnagel, Lars (Bruker 201912 VP + General Manager of Luxendo Business) |
General Manager (management) |
Bruker (Group) |
Germany |
| Hufnagel, Peter (Bruker 200712 Bruker Daltonik GmbH Project Manager ProteinScape) |
Product Manager (personnel) |
Bruker (Group) |
Germany |
| Hug, Peter (Roche Pharma Partnering 200511) |
n. a. |
Roche (Group) |
Switzerland |
| Hughes, Owen (MPM Capitap 201710 Managing Director + Cullinan Oncology 201710– CEO before Intarcia + 16y at Wall Street) |
Managing Director |
MPM Capital (Group) |
United States (USA) |
| Hughes, Thomas E. (Tom) (Navitor Pharmaceuticals 202002 CEO before Zafgen 2008–2017 before Novartis) |
Chief Executive Officer (CEO) |
Navitor Pharmaceuticals Inc. |
United States (USA) |
| Huhle, Doreen (Hamburg (govt) 201208 Investment Manager at Innovationsstarter Hamburg GmbH) |
Investment Manager |
Hamburg (govt region) |
Germany |
| Huhmer, Andreas (Nautilus Biotechnology 202310– Sr Director Scienctific Affairs + Alliance Mgt before Thermo Fisher) |
Sales Manager / Marketing Manager |
Nautilus Biotechnology (Group) |
United States (USA) |
| Huiskamp, Chris (Isarna Therapeutics 202109 CFO) |
Chief Financial Officer (CFO) |
Isarna Therapeutics GmbH |
Germany |
| Huisman, Arnoud (Nuvisan 202209 Managing Director of Nuvisan ICB + Chief Strategy Officer of Nuvisan Group) |
Managing Director |
Nuvisan (Group) |
Germany |
| Huland, Edith (Immunservice GmbH 201205 Managing Director) |
Managing Director |
Immunservice GmbH |
Germany |
| Hulot, Thierry (Merck (DE) 201310– Head of Global Manufacturing + Supply at Merck Serono joined Merck 1995) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
Germany |
| Humbey, Olivier (Accovion 201412– Country Director France) |
Regional manager |
Clinipace (Group) |
France |
| Humer, Franz B. (Roche –2014 non-exec Chairman before CEO) |
Board member, non-executive |
Roche (Group) |
Switzerland |
| Hummel, Berthold (Baker McKenzie 202106 before Dechert) |
Attorney / Lawyer |
Baker McKenzie LLP |
United States (USA) |
| Humpf, Hans-Ulrich (Univ Münster 201305 Professor) |
Professor |
University of Münster (Westfälische Wilhelms-Universität Münster) |
Germany |
| Humphries, Paul (Flextronics 201806 President High-reliability Solutions) |
n. a. |
Flextronics (d/b/a Flex) (Group) |
Singapore |
| Humphrys, Emily (Cambridge Research Biochemicals 202305 Managing Director) |
Managing Director |
Biosynth (since 9/22) (Group) |
United Kingdom (GB) |
| Hundle, Bhupinder (Eucodis 200910– VP Marketing and Sales) |
Sales Manager / Marketing Manager |
Biosynth (since 9/22) (Group) |
Austria |
| Hundt, Morten (MIRO Analytical 2018– CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Bruker (Group) |
Switzerland |
| Hung, David T. (Nuvation Bio 202408 CEO + Founder before Axovant + Medivation + ProDuct Health) |
Chief Executive Officer (CEO) |
Nuvation Bio Inc. |
United States (USA) |
| Hunkapiller, Michael (Mike) (Pacific Biosciences 201201–202009 CEO before Alloy Ventures + ABI President RETIRED 12/20) |
Chief Executive Officer (CEO) |
Pacific Biosciences (PacBio) (Group) |
United States (USA) |
| Hunkapiller, Tim (Disocovery Biosciences + Univ of Washington + Caltech) |
Researcher (university / research institute) |
Discovery Biosciences Corporation |
United States (USA) |
| Hunneyball, Ian M. |
n. a. |
Evotec (Group) |
Germany |
| Hunt, Stewart (InSphero 201602 General Manager at InSphero Inc) |
General Manager (management) |
InSphero (Group) |
United States (USA) |
| Hunter, Brian (Coral BioNet 201702 of BioNet Ventures) |
Managing Director |
Coral BioNet (Group) |
Germany |
| Huntsman, Peter R. (Huntsman 201710 CEO) |
n. a. |
Huntsman (Group) |
United States (USA) |
| Hurly, Stephen (Lava Therapeutics 202005 CEO formerly 201307 CEO of Burrill Securities LLC) |
Chief Executive Officer (CEO) |
Lava Therapeutics (Group) |
Netherlands |
| Huse, Tim (Humboldt Univ 202409 at BIH) |
n. a. |
Humboldt University Berlin |
Germany |
| Huser, Monique (Roche 200612) |
n. a. |
Roche (Group) |
Switzerland |
| Huss, Ralf (Bavaria (govt) 202301– Managing Director of BioM before Augsburg Univ Hospital + Definiens + Apceth + Roche) |
Cluster Manager |
Bavaria (govt region) |
Germany |
| Husslein, Volker (GSK 201703 Head Communications at GSK Vaccines GmbH) |
Public Relations Manager / Investor Relations Manager |
GSK (Group) |
Germany |
| Hustert, Elisabeth (Scil) |
n. a. |
Coral BioNet (Group) |
Germany |
| Hutchinson, David B. A. (BioAgency 201102 Managing Director of Jomaa Pharma GmbH) |
Managing Director |
BioAgency AG |
Germany |
| Huth, Johannes (KKR 201506 Head KKR Europea, Afria + Middle East) |
President/Director/Head Business Group/Unit/Division |
KKR (Kohlberg Kravis Roberts) (Group) |
United States (USA) |
| Hutter, Bernd (Berthold Technologies 201107 Head Bioanalytical Instruments) |
President/Director/Head Business Group/Unit/Division |
Berthold Technologies (Group) |
Germany |
| Huuk, Thiemo (GoSilico 202106 Co-CEO + Co-Founder) |
Chief Executive Officer (CEO) |
GoSilico GmbH |
Germany |
| Huxley, Alice (Speedel 200701 CEO) |
Chief Executive Officer (CEO) |
Novartis (Group) |
Switzerland |
| Huybens, Alex (Droege 202107–202409 promoted CEO of HAL Allergy Holidng + Halix joined in 2003 LEFT 9/24) |
Chief Executive Officer (CEO) |
Droege (Group) |
Netherlands |
| Hušman, Dejan (DenovoMatrix 201902 Managing Director) |
Managing Director |
DenovoMatrix GmbH |
Germany |
| Hübler, Karl (Eucodis Bioscience GmbH 201604 CEO) |
Chief Executive Officer (CEO) |
Biosynth (since 9/22) (Group) |
Austria |
| Hübner, Marc (R-Biopharm 201605 Sales Manager Germany + Austria) |
Sales Manager / Marketing Manager |
R-Biopharm (Group) |
Germany |
| Hübner, Michael R. (JnJ 202404 Early Innovation Partner at J&J Innovation) |
Business Development Manager / Strategy Manager |
Johnson & Johnson (JnJ) (Group) |
Switzerland |
| Hübschmann, Hans-Joachim (CTC Analytics 201511 VP Sales Asia before Thermo Fisher) |
Technical Manager |
CTC Analytics AG |
Japan |
| Hüls, Christoph (Merck KGaA 200808– VP Operational Excellence Research before Protagen CEO) |
Research & Development Manager |
Merck (DE) (Group) |
Germany |
| Hyman, Anthony (Tony) (Max Planck 201901 Group Leader at MPI-CBG Dresden + Co-Founder Dewpoint Therapeutics) |
Researcher (university / research institute) |
Max Planck Society for the Advancement of Science |
Germany |
| Hüppe, Paul (Rehberg Hüppe + Partner 201409 Patent Attorney) |
Patent Attorney |
Rehberg Hüppe + Partner Patentanwälte PartG mbB (RHP) |
Germany |
| Hüttl, Reinhard F. (acatech 201002 + Member BioÖkonomieRat) |
Professor |
acatech – Deutsche Akademie der Technikwissenschaften |
Germany |
| Hüttner, Steffen (Hölle & Hüttner 200807 Managing Director + Founder) |
Managing Director |
HB Technologies (Group) |
Germany |
| Hyvelin, Jean-Marc (Stalicla 202002 COO) |
Chief Operating Officer (COO) |
Stalicla S.A. |
Switzerland |
| Hyvert, Jean-Christophe (Lonza 202105 President Biologics and Cell + Gene) |
President/Director/Head Business Group/Unit/Division |
Lonza (Group) |
Switzerland |
| Häckel, Marko (Neoplas GmbH 201206 Managing Director) |
Managing Director |
Neoplas GmbH |
Germany |
| Hämmerle, Hugo (Univ Tübingen 201204 Prof + Head of NMI) |
Researcher (university / research institute) |
University of Tübingen (Eberhard-Karls-Universität) |
Germany |
| Hänggi, Rolf (200808 before Roche VP) |
n. a. |
Roche (Group) |
Switzerland |
| Häßner, Tobias (Tecan Deutschland 200809) |
Sales Manager / Marketing Manager |
Tecan (Group) |
Germany |
| Höfer, Constance (Priaxon 201401– Chief Development Officer before Medigene + Merck KGaA + Solvay) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Priaxon AG |
Germany |
| Höfgen, Norbert (DyNAbind GmbH 201705– Managing Director (COO) + Co-Founder) |
Managing Director |
DyNAbind GmbH |
Germany |
| Höfler, Gerald (Medical Univ Graz 201308 Professor at Institute for Pathology) |
Professor |
Medical University Graz (MedUni Graz) |
Austria |
| Höger, Thomas (Apogenix 200511– CEO + CFO before since 10/00 DZ Bank before BASF/Knoll) |
Chief Executive Officer (CEO) |
Apogenix AG |
Germany |
| Höhling, Axel (ANiMOX GmbH 200810 Managing Director) |
Managing Director |
Animox GmbH |
Germany |
| Höller, Kurt (EU (govt) 202012 Director of Business Creation at EIT Health) |
n. a. |
EU (govt) |
Germany |
| Höppner, Oliver (KeyNeurotek 200305– before interim management for biotchs + GenProfile AG + Noxxon) |
n. a. |
KeyNeurotek (Group) |
Germany |
| Iacone, Roberto (Alentis Therapeutics 202007– CEO before Versant Ventures + Roche) |
Chief Executive Officer (CEO) |
Alentis Therapeutics AG |
Switzerland |
| Iann, Max Markus (Iann 2012– Founder) |
Investment Manager |
Iann (Group) |
Germany |
| Iannone, Lucio (Bayer 201904 at Leaps by Bayer) |
Investment Manager |
Bayer (Group) |
|
| Ibbotson, Peter (Swisscom 202209 Partner at Swisscom Ventures) |
Partner (venture partner) |
Swisscom (Group) |
Switzerland |
| Ibrahim, Adrian (Wellcome Trust 202101 Head of Technology Transfer + Business Development at Sanger Institute) |
IP Manager |
Wellcome Trust, The |
United Kingdom (GB) |
| Icheln, Bärbel (Peptrotech GmbH 200705) |
n. a. |
Thermo Fisher (Group) |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 35 36 37 ... 93 94 95 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
